A new Centers for Disease Control and Prevention report offers guidance on the preexposure use of the JYNNEOS smallpox and monkeypox vaccine for individuals at risk for occupational exposure to orthopoxviruses. The recommendations were made by the CDC’s Advisory Committee on Immunization Practices. The committee recommends preexposure vaccination for people who work in laboratories doing research on orthopoxviruses; people who work in clinical laboratories performing testing to diagnose orthopoxviruses, certain people responding to orthopoxvirus-related public health investigations; and health care personnel who care for patients infected with orthopoxviruses or administer the ACAM2000 vaccine.

Related News Articles

Headline
The World Health Organization Aug. 14 declared a global health emergency due to the recent mpox outbreak in Africa, the second mpox declaration in two years.…
Headline
The Centers for Disease Control and Prevention has updated respiratory syncytial virus vaccination recommendations for adults 60 and older. Adults aged 60-74…
Headline
The AHA along with the Association for the Health Care Environment recently released the Environmental Services Competency Resource Search Catalog, which…
Headline
At a Capitol Hill briefing July 31, hospital and health care leaders shared strategies and stories highlighting the importance of passing the Safety from…
Headline
Antimicrobial-resistant infections remained above pre-pandemic levels in 2022, the Centers for Disease Control and Prevention reported July 16. CDC data show…
Headline
The Centers for Disease Control and Prevention July 14 announced four confirmed human cases of H5N1 bird flu among farm workers who were working at a Colorado…